PL2015767T3 - Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego - Google Patents

Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego

Info

Publication number
PL2015767T3
PL2015767T3 PL07748079T PL07748079T PL2015767T3 PL 2015767 T3 PL2015767 T3 PL 2015767T3 PL 07748079 T PL07748079 T PL 07748079T PL 07748079 T PL07748079 T PL 07748079T PL 2015767 T3 PL2015767 T3 PL 2015767T3
Authority
PL
Poland
Prior art keywords
antisecretory factor
intraocular hypertension
treating intraocular
treating
hypertension
Prior art date
Application number
PL07748079T
Other languages
English (en)
Inventor
Hans-Arne Hansson
Stefan Lange
Eva Jennische
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of PL2015767T3 publication Critical patent/PL2015767T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PL07748079T 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego PL2015767T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27
PCT/SE2007/000414 WO2007126364A2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension
EP07748079.6A EP2015767B1 (en) 2006-04-27 2007-04-27 Use of antisecretory factor for treating intraocular hypertension

Publications (1)

Publication Number Publication Date
PL2015767T3 true PL2015767T3 (pl) 2016-05-31

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07748079T PL2015767T3 (pl) 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Country Status (18)

Country Link
US (2) US8207296B2 (pl)
EP (2) EP2015767B1 (pl)
JP (2) JP5284948B2 (pl)
KR (1) KR20090040404A (pl)
CN (2) CN101432013B (pl)
AU (1) AU2007244004B2 (pl)
BR (1) BRPI0710959B8 (pl)
CA (2) CA2771087C (pl)
DK (2) DK2015767T3 (pl)
ES (2) ES2561945T3 (pl)
IL (1) IL194773A (pl)
MX (1) MX2008013769A (pl)
NZ (2) NZ572255A (pl)
PL (2) PL2015767T3 (pl)
RU (1) RU2458703C2 (pl)
SG (1) SG171602A1 (pl)
WO (1) WO2007126364A2 (pl)
ZA (1) ZA200809115B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090040404A (ko) * 2006-04-27 2009-04-24 란트만넨 아스-팍토르 아베 고안압증 치료를 위한 항분비 인자의 용도
US9220750B2 (en) 2007-04-27 2015-12-29 Lantmannen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
EP2934564B1 (en) * 2012-12-20 2018-05-23 Lantmännen AS-Faktor AB Antisecretory factor (af) for use in the treatment of glioblastoma
EP3319618B1 (en) * 2015-07-10 2021-06-16 Lantmännen Functional Foods AB Process for producing egg yolk with high content of af-16
JP6999638B2 (ja) 2016-07-18 2022-01-18 ラントメネン・メディカル・アーベー 抗分泌性因子１７
WO2020002464A1 (en) 2018-06-28 2020-01-02 Lantmännen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
EP3855935A1 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted wheat
WO2020065089A2 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted dehulled oat
CA3173436A1 (en) 2020-03-26 2021-09-30 Leif Goransson A consumable product comprising malted cereals for promoting recovery at physical activity
WO2024102346A1 (en) * 2022-11-08 2024-05-16 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE506486C2 (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
WO2001005968A1 (en) * 1999-06-21 2001-01-25 Inkine Pharmaceutical Company, Inc. Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
WO2007126365A2 (en) * 2006-04-27 2007-11-08 Lantmännen As-Faktor Ab Further medical uses of antisecretory protein
DK2363140T3 (en) * 2006-04-27 2017-03-06 Lantmännen As-Faktor Ab ANTI-SECRETORIC PROTEIN TO USE IN THE TREATMENT OF COMPARTMENT SYNDROME
KR20090040404A (ko) * 2006-04-27 2009-04-24 란트만넨 아스-팍토르 아베 고안압증 치료를 위한 항분비 인자의 용도

Also Published As

Publication number Publication date
BRPI0710959B1 (pt) 2018-11-06
WO2007126364A8 (en) 2009-07-23
EP2468292A1 (en) 2012-06-27
BRPI0710959B8 (pt) 2021-05-25
PL2468292T3 (pl) 2020-08-24
NZ572255A (en) 2012-03-30
JP5284948B2 (ja) 2013-09-11
US8207296B2 (en) 2012-06-26
CN102633863A (zh) 2012-08-15
US20120283191A1 (en) 2012-11-08
CN101432013A (zh) 2009-05-13
ZA200809115B (en) 2009-07-29
CA2650344C (en) 2017-10-31
DK2015767T3 (en) 2016-02-08
EP2468292B8 (en) 2020-02-26
MX2008013769A (es) 2009-02-03
US9000125B2 (en) 2015-04-07
JP2012153695A (ja) 2012-08-16
DK2468292T3 (da) 2020-03-23
KR20090040404A (ko) 2009-04-24
ES2561945T3 (es) 2016-03-01
RU2008146733A (ru) 2010-06-10
JP2009535329A (ja) 2009-10-01
RU2458703C2 (ru) 2012-08-20
ES2773945T3 (es) 2020-07-15
EP2015767B1 (en) 2016-01-06
AU2007244004A1 (en) 2007-11-08
NZ598426A (en) 2012-08-31
EP2468292B1 (en) 2019-12-18
WO2007126364A2 (en) 2007-11-08
EP2015767A2 (en) 2009-01-21
IL194773A (en) 2015-07-30
CA2650344A1 (en) 2007-11-08
CN101432013B (zh) 2015-01-07
US20090162296A1 (en) 2009-06-25
CA2771087C (en) 2016-03-15
WO2007126364A3 (en) 2008-03-06
SG171602A1 (en) 2011-06-29
CN102633863B (zh) 2014-08-06
CA2771087A1 (en) 2007-11-08
IL194773A0 (en) 2011-08-01
BRPI0710959A2 (pt) 2012-02-28
AU2007244004B2 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
PL2015767T3 (pl) Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
EP2324029A4 (en) HETEROCYCLIC HEMMER OF HISTAMINE RECEPTORS FOR DISEASE TREATMENT
EP2320904A4 (en) AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
HK1146484A1 (en) Thiazolidinedione analogues for the treatment of hypertension
ZA200903233B (en) Quinazolines for PDK1 inhibition
ZA200808307B (en) Quinazolines for PDK1 inhibition
HK1134639A1 (zh) 用於治療骨盆的手術物品
ZA200810105B (en) Means for controlling the progression of myopia
ZA200903533B (en) Process for the preparation of rosuvastatin
GB0624977D0 (en) Artificial candle
IL198005A0 (en) Ccr2 antagonists for treatment of fibrosis
EP1940397A4 (en) METHOD FOR TREATING HYPERTONIA
GB2446944B (en) Removal of prosthesis
GB0609402D0 (en) Prosthesis
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
EP1993535A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
EP2165185A4 (en) CONTROLLED MODIFICATION OF SEMICONDUCTOR NANOCRYSTALLES
EP2013404A4 (en) OPERATING PROCESS FOR DRYERS
IL198941A0 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
EP1993536A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP1993537A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP2032130A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF EYE HIGH PRESSURE
ZA200807615B (en) Renin inhibitors for the treatment of hypertension
EP1993538A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
GB0820885D0 (en) A composition for the treatment of hypertension